Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225K Buy
2,477
+314
+15% +$28.7K 0.12% 103
2026
Q1
$222K Sell
2,163
-12
-0.6% -$1.35K 0.12% 99
2025
Q4
$272K Sell
2,175
-5,434
-71% -$692K 0.16% 90
2025
Q3
$1.02M Sell
7,609
-22
-0.3% -$2.89K 0.65% 37
2025
Q2
$1.04M Buy
7,631
+154
+2% +$20.3K 0.7% 38
2025
Q1
$992K Sell
7,477
-83
-1% -$10.6K 0.8% 33
2024
Q4
$855K Sell
7,560
-52
-0.7% -$6.01K 0.68% 35
2024
Q3
$868K Sell
7,612
-481
-6% -$52.8K 0.7% 34
2024
Q2
$841K Buy
8,093
+234
+3% +$24.8K 0.7% 40
2024
Q1
$893K Sell
7,859
-106
-1% -$12.2K 0.81% 35
2023
Q4
$877K Buy
+7,965
New +$796K 0.86% 36
2021
Q4
$1.08M Buy
+7,670
New +$982K 1.14% 32

Other funds holding ABT

Finivi Inc's ABT Position: Q2 2026 in Review

Finivi Inc increased its Abbott (ABT) stake by 15% in Q2 2026, buying an estimated $28.7K and bringing the position to 2,477 shares worth $225K. The position accounts for 0.12% of the portfolio, ranked #103.

Finivi Inc first reported a position in ABT in Q4 2021 and has held it in 12 quarters since. The position peaked at $1.08M in Q4 2021. 2,917 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Finivi Inc held 2,477 shares of Abbott worth $225K as of Q2 2026.
  • Finivi Inc bought 314 Abbott shares in Q2 2026, an estimated $28.7K.
  • Abbott made up 0.12% of Finivi Inc's portfolio in Q2 2026, its #103 holding.
  • Finivi Inc first reported a position in Abbott in Q4 2021 and has held it in 12 quarters since.
  • Finivi Inc's Abbott position peaked at $1.08M in Q4 2021.
  • 2,917 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Finivi Inc's 13F filing for Q2 2026, filed 9 Jul 2026.